Updates in Primary Biliary Cholangitis
Updates in Primary Biliary Cholangitis
Updates in Primary Biliary Cholangitis
Updates in Primary Biliary Cholangitis
Speaker: Ari Bunim, MD, AGAF
Dr. Ari Bunim received his Medical Degree from New York University Medical School, and completed his Internship and Residency in Internal Medicine at the Hospital of the University of Pennsylvania. He obtained Fellowships in Gastroenterology, and Hepatology and Liver Transplantation at Montefiore Medical Center/Albert Einstein College of Medicine.
He is the former Clinical Director of Hepatology at New York-Presbyterian/Queens, where he also previously served as an Attending Physician. While there, he ran the weekly hepatobiliary clinic, supervising both residents and fellows. Dr. Bunim is a Clinical Assistant Professor at Albert Einstein College of Medicine. In 2018, he received the Hepatitis C Clinical Exchange Network Champion Award from the New York City Department of Health and Mental Hygiene. Dr. Bunim was named among the Top 15 Doctors for state-of-the-art medical care by It’s Queens Magazine in 2015.
Dr. Bunim treats a wide range of gastrointestinal and liver disorders including GERD, GI bleeding, abdominal pain, inflammatory bowel disease, hepatitis, fatty liver, and liver lesions. His research interests include viral hepatology, fatty liver disease, portal hypertension, and hepatocellular carcinoma. He has been involved in clinical trials and presents his research at national meetings.
Board certified in both Gastroenterology and Internal Medicine, Dr. Bunim serves as a member of the American Gastroenterology Association, American Association for the Study of Liver Diseases, the American College of Gastroenterology and the Empire Liver Foundation.
Register for PBC Updates
Updates in Primary Biliary Cholangitis
Speaker: Arun Jesudian, MD
Dr. Jesudian is a Transplant Hepatologist whose research focuses on improving outcomes in patients with cirrhosis and complications of portal hypertension through quality improvement. He is an Associate Professor of Clinical Medicine, Director of Liver Quality and Inpatient Liver Services at NewYork-Presbyterian Hospital/Weill Cornell Medicine. He serves as a member of the Practice Metrics Committee and as site principal investigator for the Cirrhosis Quality Collaborative.
Register for PBC Updates
Updates in Primary Biliary Cholangitis
Speaker: Nikolaos Pyrsopoulos, MD, MBA, PhD
Dr. Pyrsopoulos currently serves as Professor at NYU and Regional Director Liver Disease in New Jersey. He completed his medical degrees (MD and PhD) at the University of Athens in Greece, followed by residency and fellowships in Athens Greece, and the University of Miami, Miller School of Medicine. Dr. Pyrsopoulos is board-certified in the areas of Internal Medicine, Gastroenterology, and Transplant Hepatology. He received his M.B.A. from the University of Miami School of Business.
Nikolaos’ publications include various scientific journals, including the Journal of Gastroenterology, Hepatology, and Transplantation, and one of the authors of a unique in the field of abdominal transplantation book: Intestinal and visceral transplantation. Dr. Pyrsopoulos is also a Fellow of The American College of Physicians, the American Gastroenterological Association, The American College of Gastroenterology, The American Association for the Study of Liver Diseases, and the Royal College of Physicians (Edinburgh). He is a member of various medical associations such as the American Association of the Study of Liver Diseases, The European Association of the Study of the Liver, the American Society of Gastrointestinal Endoscopy, and the American Society of Transplantation, among others. He has served on numerous national and institutional committees. He has participated in multiple international and national research projects. His vision is excellence in patient care, providing outstanding education to the fellows, residents, and students, and promoting the science of medicine by conducting research.
Register for PBC Updates
Updates in Primary Biliary Cholangitis
Speaker: Harmit Kalia, DO
Dr. Kalia is the Director of Strategic Development and Outreach – Center for Liver Disease and Transplantation at Northwell Health. Dr. Kalia is a Transplant Hepatologist received his medical education at the New York College of Osteopathic Medicine in Old Westbury, and then took four years of Internal Medicine Residency, the first three at UMDNJ in Newark and the next as a Chief Resident at the East Orange VA. He completed a Transplant Hepatology Fellowship at Mount Sinai Medical Center in New York City, and Gastroenterology Fellowship at UMDNJ-New Jersey Medical School, Newark NJ. From 2009-2019 was at Montefiore Medical center. He is a clinical Associate Professor of Medicine and joined the NYU Transplant Institute in August ‘19 and continues to take care of patients with Liver diseases. Dr. Kalia’s clinical and research interests include NAFLD, Hepatitis B, Hepatitis C, Autoimmune Hepatitis, complications of end stage liver disease and liver transplantation.
Register for PBC Updates
Updates in Primary Biliary Cholangitis
Speaker: Arun Jesudian, MD
Dr. Jesudian is a Transplant Hepatologist whose research focuses on improving outcomes in patients with cirrhosis and complications of portal hypertension through quality improvement. He is an Associate Professor of Clinical Medicine, Director of Liver Quality and Inpatient Liver Services at NewYork-Presbyterian Hospital/Weill Cornell Medicine. He serves as a member of the Practice Metrics Committee and as site principal investigator for the Cirrhosis Quality Collaborative.
Register for PBC Updates
Updates in Primary Biliary Cholangitis
As the director of hepatology at NYU Langone Health, Ira Jacobson aims to expand and enhance the clinical, research, and educational programs in liver disease and mentor the exceptional group of hepatologists. “For more than 30 years, I have participated in hundreds of clinical trials on antiviral therapy for viral hepatitis, including hepatitis B and C, and I have also led a number of them. These studies have remarkably improved our ability to treat people with these conditions, including the capacity to cure nearly all patients who have hepatitis C. I have authored and coauthored more than 250 scientific papers, chapters, and reviews on these and other topics. I continue to be involved in studies on viral hepatitis, and am also involved in studies examining treatments for other liver diseases, such as fatty liver disease and primary biliary cholangitis.”
Continue reading